Koers Rafina Innovations Inc.
Aandelen
VICA
US75063R1068
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,003 USD | +2.900,00% |
|
-.--% | +2.900,00% |
3 maanden | +2.900,00% | ||
6 maanden | +100,00% |
Omzet 2017 | 0,36 0,33 | Omzet 2018 | 0,41 0,39 | Marktkapitalisatie | 5,04 mln. 4,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2018 | -5 mln. -4,66 mln. | EV/omzet 2017 | 23.123.686 x |
Nettoliquiditeiten 2017 | 0,3 0,28 | Nettoschuld 2018 | 0,06 0,06 | EV/omzet 2018 | 12.220.928 x |
K/w-verhouding 2017 |
-2,4
x | K/w-verhouding 2018 |
-0,82
x | Werknemers | 4 |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 99% |
1 dag | +2.900,00% | ||
3 maanden | +2.900,00% | ||
6 maanden | +100,00% |
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roger Pawson
CEO | Chief Executive Officer | 71 | - |
Director of Finance/CFO | 35 | 03-10-18 | |
Hari Elangovan
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Pawson
CEO | Chief Executive Officer | 71 | - |
Yannis Levantis
BRD | Director/Board Member | 48 | 18-06-15 |
Director/Board Member | 79 | 15-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2.900,00% | 417K | |
-4,56% | 182 mld. | |
-3,71% | 103 mld. | |
-4,80% | 66,94 mld. | |
+11,18% | 46,73 mld. | |
-8,41% | 45,14 mld. | |
+5,82% | 41,57 mld. | |
+17,29% | 30,48 mld. | |
+14,00% | 24,26 mld. | |
-6,64% | 23,58 mld. |